https://medicaldialogues.in/news/industry/pharma/revise-phase-iii-ct-protocol-of-recombinant-rabies-g-protein-vaccine-to-add-safety-cdsco-panel-tells-cadila-103461
0
0
Revise phase III CT protocol of Recombinant Rabies G Protein Vaccine to add safety: CDSCO Panel tells... - Medical Dialogues
12/4/22 at 8:14am
Organization
Medical Dialogues
Author
Medical Dialogues Team
Details
45 words
Summarize
Health phase III CT protocol Recombinant Rabies Cadila Pharmaceuticals CDSCO Panel CDSCO New Delhi: The Subject Expert Committee
New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has recommended the vaccine maker Cadila Pharmaceuticals that Phase III...
Create an account or login to join the discussion